Anti-SSA/Ro
Also known as: Ro Antibodies, SSA Antibodies
What Does Anti-SSA/Ro Measure?
Anti-SSA/Ro antibodies are autoantibodies that target specific proteins found in the nucleus and cytoplasm of human cells, particularly the Ro52 and Ro60 ribonucleoproteins. These proteins are involved in RNA processing and quality control within cells. The test measures whether your immune system has mistakenly produced antibodies against these 'self' proteins, which is a hallmark of certain autoimmune conditions. Results are typically reported as positive or negative, with positive results sometimes accompanied by a titer (concentration level) or antibody units.
Why Does Anti-SSA/Ro Matter?
Anti-SSA/Ro antibodies are clinically significant because they are strongly associated with autoimmune diseases, most notably Sjögren's syndrome and systemic lupus erythematosus (SLE). Their presence can help diagnose these conditions, predict disease complications, and guide treatment decisions. Critically, these antibodies can cross the placenta during pregnancy, posing risks to the developing fetus including neonatal lupus and congenital heart block — a potentially life-threatening condition where the baby's heart rhythm is disrupted. Monitoring Anti-SSA/Ro levels in pregnant women with autoimmune diseases is therefore an important part of prenatal care.
Normal Ranges
Males
Negative (< 1.0 U or < 20 AU/mL, depending on lab methodology)
Females
Negative (< 1.0 U or < 20 AU/mL, depending on lab methodology)
Children
Negative (same threshold as adults; interpretation varies by clinical context)
Causes of High Levels
- Sjögren's syndrome (primary or secondary) — the most common association, present in up to 70-75% of patients
- Systemic lupus erythematosus (SLE) — found in approximately 25-60% of SLE patients
- Subacute cutaneous lupus erythematosus (SCLE) — very strongly associated, present in over 70% of cases
- Neonatal lupus — maternal antibodies transferred to the fetus causing transient autoimmune symptoms
- Mixed connective tissue disease (MCTD) or undifferentiated connective tissue disease
- Rheumatoid arthritis with secondary Sjögren's syndrome overlap
Causes of Low Levels
- No autoimmune disease present — a negative result is the expected finding in healthy individuals
- Successful immunosuppressive therapy reducing overall autoantibody production
How to Improve Your Anti-SSA/Ro
Diet
- Adopt an anti-inflammatory diet rich in omega-3 fatty acids from fatty fish (salmon, mackerel, sardines) to help modulate immune activity
- Increase intake of colorful fruits and vegetables high in antioxidants (berries, leafy greens, cruciferous vegetables) to reduce oxidative stress
- Minimize pro-inflammatory foods such as refined sugars, processed foods, and trans fats that may worsen autoimmune activity
- Consider a Mediterranean-style diet, which has shown benefits in reducing systemic inflammation in autoimmune conditions
- Stay well-hydrated and limit alcohol, which can trigger flares and impair immune regulation
Supplements
- Vitamin D3 (1,000–4,000 IU/day depending on baseline levels) — deficiency is common in autoimmune diseases and may worsen immune dysregulation
- Omega-3 fish oil (2–4 g/day EPA+DHA) — has documented anti-inflammatory effects that may support immune balance
- Magnesium (300–400 mg/day) — supports immune function and is commonly depleted in autoimmune conditions
- Probiotics (multi-strain, 10–50 billion CFU/day) — emerging evidence suggests gut microbiome balance influences autoimmune activity
Related Biomarkers
Frequently Asked Questions
What does a positive Anti-SSA/Ro test mean?
A positive Anti-SSA/Ro result means your immune system has produced antibodies against the Ro protein found in your own cells. This is associated with autoimmune conditions, most commonly Sjögren's syndrome and lupus (SLE). However, a positive result alone does not diagnose a specific disease — your doctor will interpret it alongside your symptoms, physical examination, and other laboratory tests. A small percentage of healthy individuals, particularly older women, can also test weakly positive without having an autoimmune disease.
Can Anti-SSA/Ro antibodies affect pregnancy?
Yes, this is one of the most clinically important aspects of Anti-SSA/Ro antibodies. These antibodies can cross the placenta and reach the developing baby, potentially causing neonatal lupus — a condition where the newborn temporarily shows lupus-like symptoms such as a skin rash and low blood cell counts. More seriously, they can cause congenital heart block, a disruption of the baby's heart electrical conduction system that can be life-threatening and may require a pacemaker. Women who are pregnant or planning pregnancy and have known Anti-SSA/Ro antibodies should receive close fetal cardiac monitoring, typically with echocardiography between weeks 16–26 of pregnancy.
What is the difference between Anti-SSA/Ro and Anti-SSB/La?
Anti-SSA/Ro and Anti-SSB/La are both autoantibodies associated with Sjögren's syndrome and lupus, but they target different proteins. Anti-SSA/Ro targets the Ro52 and Ro60 ribonucleoprotein complexes, while Anti-SSB/La targets a protein involved in RNA polymerase III function. Anti-SSB/La is less common and is rarely found without Anti-SSA/Ro being present as well. When both antibodies are present together, it is highly suggestive of Sjögren's syndrome. Anti-SSA/Ro carries greater clinical significance for pregnancy complications, while the combination of both is sometimes associated with a milder lupus disease course.